Dietary Aromatic Amino Acid Requirements During Early and Late Gestation in Healthy Pregnant Women.


Journal

The Journal of nutrition
ISSN: 1541-6100
Titre abrégé: J Nutr
Pays: United States
ID NLM: 0404243

Informations de publication

Date de publication:
10 12 2020
Historique:
received: 19 06 2020
revised: 07 08 2020
accepted: 22 09 2020
pubmed: 15 11 2020
medline: 28 1 2021
entrez: 14 11 2020
Statut: ppublish

Résumé

Phenylalanine and tyrosine (referred to as total aromatic amino acids; TAAs) are essential for protein synthesis, and are precursors for important catecholamines. Current estimated average requirement (EAR) recommendations for TAA during pregnancy are 36 mg·kg-1·d-1, and has not been experimentally determined. The aim was to determine TAA requirements (dietary phenylalanine in the absence of tyrosine) during early and late gestation using the indicator amino acid oxidation (IAAO, with L-[1-13C]leucine) technique. Nineteen healthy pregnant women (age 22-38 y) were studied at a range of phenylalanine intakes (5 to 100 mg·kg-1·d-1) in early (13-19 wk) and/or late (33-39 wk) pregnancy for a total of 51 study days. Graded test intakes were provided as 8 hourly isonitrogenous and isocaloric meals. Breath samples were collected for 13C enrichment analysis on an isotope ratio mass spectrometer. A plasma sample was collected and analyzed for phenylalanine and tyrosine concentrations on an amino acid analyzer. The TAA requirement in early and late pregnancy was calculated using 2-phase linear regression crossover analysis that identified breakpoints in 13CO2 production (the requirement) in response to phenylalanine intakes. TAA requirement during early pregnancy was 44 mg·kg-1·d-1 (95% CI: 28.3, 58.8) and during late pregnancy was 50 mg·kg-1·d-1 (95% CI: 36.1, 63.1). In early and late pregnancy, plasma phenylalanine and tyrosine concentrations rose linearly in response to graded phenylalanine intakes. Our results suggest that the current EAR of 36 mg·kg-1·d-1 for TAAs is underestimated. When compared with results previously determined in nonpregnant adults, early pregnancy requirements were similar (43 compared with 44 mg·kg-1·d-1, respectively). During late pregnancy, a 14% higher TAA requirement was observed when compared with early pregnancy. The results from this study have potential implications for creating gestation stage-specific TAA recommendations.

Sections du résumé

BACKGROUND
Phenylalanine and tyrosine (referred to as total aromatic amino acids; TAAs) are essential for protein synthesis, and are precursors for important catecholamines. Current estimated average requirement (EAR) recommendations for TAA during pregnancy are 36 mg·kg-1·d-1, and has not been experimentally determined.
OBJECTIVES
The aim was to determine TAA requirements (dietary phenylalanine in the absence of tyrosine) during early and late gestation using the indicator amino acid oxidation (IAAO, with L-[1-13C]leucine) technique.
METHODS
Nineteen healthy pregnant women (age 22-38 y) were studied at a range of phenylalanine intakes (5 to 100 mg·kg-1·d-1) in early (13-19 wk) and/or late (33-39 wk) pregnancy for a total of 51 study days. Graded test intakes were provided as 8 hourly isonitrogenous and isocaloric meals. Breath samples were collected for 13C enrichment analysis on an isotope ratio mass spectrometer. A plasma sample was collected and analyzed for phenylalanine and tyrosine concentrations on an amino acid analyzer. The TAA requirement in early and late pregnancy was calculated using 2-phase linear regression crossover analysis that identified breakpoints in 13CO2 production (the requirement) in response to phenylalanine intakes.
RESULTS
TAA requirement during early pregnancy was 44 mg·kg-1·d-1 (95% CI: 28.3, 58.8) and during late pregnancy was 50 mg·kg-1·d-1 (95% CI: 36.1, 63.1). In early and late pregnancy, plasma phenylalanine and tyrosine concentrations rose linearly in response to graded phenylalanine intakes.
CONCLUSIONS
Our results suggest that the current EAR of 36 mg·kg-1·d-1 for TAAs is underestimated. When compared with results previously determined in nonpregnant adults, early pregnancy requirements were similar (43 compared with 44 mg·kg-1·d-1, respectively). During late pregnancy, a 14% higher TAA requirement was observed when compared with early pregnancy. The results from this study have potential implications for creating gestation stage-specific TAA recommendations.

Identifiants

pubmed: 33188409
pii: S0022-3166(22)02415-4
doi: 10.1093/jn/nxaa317
pmc: PMC7726121
doi:

Substances chimiques

Amino Acids, Aromatic 0
Carbon Isotopes 0
Tyrosine 42HK56048U
Phenylalanine 47E5O17Y3R

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3224-3230

Subventions

Organisme : CIHR
ID : FRN 10321
Pays : Canada

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the American Society for Nutrition.

Références

Am J Clin Nutr. 2020 Feb 1;111(2):351-359
pubmed: 31758682
Poult Sci. 2002 Apr;81(4):481-4
pubmed: 11989747
Am J Physiol. 1989 Sep;257(3 Pt 1):E426-38
pubmed: 2551178
Am J Clin Nutr. 2001 Feb;73(2):276-82
pubmed: 11157324
Hum Nutr Clin Nutr. 1985 May;39(3):167-79
pubmed: 3874856
J Clin Biochem Nutr. 2011 Sep;49(2):115-20
pubmed: 21980227
Eur J Clin Nutr. 1992 Jun;46(6):411-7
pubmed: 1639049
Nutr Res. 2014 Jul;34(7):569-76
pubmed: 25150115
Adv Nutr. 2016 Jul 15;7(4):839S-44S
pubmed: 27422521
Am J Clin Nutr. 2000 May;71(5 Suppl):1249S-55S
pubmed: 10799398
Am J Clin Nutr. 2006 Jun;83(6):1331-6
pubmed: 16762944
J Nutr. 2007 Jun;137(6 Suppl 1):1576S-1578S; discussion 1597S-1598S
pubmed: 17513429
Am J Physiol. 1990 Dec;259(6 Pt 1):E835-43
pubmed: 2260651
Br J Nutr. 1974 Jul;32(1):77-97
pubmed: 4843734
J Nutr. 2006 Jan;136(1 Suppl):281S-7S
pubmed: 16365099
J Anim Sci. 2006 Apr;84 Suppl:E155-65
pubmed: 16582088
Am J Clin Nutr. 2000 May;71(5 Suppl):1218S-25S
pubmed: 10799394
Am J Clin Nutr. 2007 Aug;86(2):360-5
pubmed: 17684206
IUBMB Life. 2013 Apr;65(4):341-9
pubmed: 23457044
Am J Clin Nutr. 1998 Apr;67(4):640-59
pubmed: 9537611
J Am Diet Assoc. 2002 Nov;102(11):1621-30
pubmed: 12449285
Am J Physiol Endocrinol Metab. 2004 Sep;287(3):E489-96
pubmed: 15308475
Amino Acids. 2016 Jul;48(7):1707-16
pubmed: 27138628
Br J Nutr. 2012 Aug;108 Suppl 2:S22-30
pubmed: 23107531
Am J Clin Nutr. 2006 Jan;83(1):82-8
pubmed: 16400054
J Nutr. 2006 Apr;136(4):958-64
pubmed: 16549457
J Nutr. 2015 Jan;145(1):73-8
pubmed: 25527661
Am J Clin Nutr. 2002 Oct;76(4):852-7
pubmed: 12324300
Am J Clin Nutr. 2008 Jul;88(1):115-24
pubmed: 18614731
J Nutr. 2018 Jan 1;148(1):94-99
pubmed: 29378056

Auteurs

Madeleine A Ennis (MA)

British Columbia Children's Hospital Research Institute, British Columbia Children's Hospital, Vancouver, Canada.
Department of Pediatrics, University of British Columbia, Vancouver, Canada.

Anna-Joy Ong (AJ)

British Columbia Children's Hospital Research Institute, British Columbia Children's Hospital, Vancouver, Canada.

Kenneth Lim (K)

Department of Obstetrics and Gynecology, British Columbia Women's Hospital, Vancouver, Canada.

Ronald O Ball (RO)

Department of Agricultural, Food and Nutritional Sciences, University of Alberta, Edmonton, Canada.

Paul B Pencharz (PB)

Research Institute, The Hospital for Sick Children, Toronto, Canada.
Department of Nutritional Sciences, University of Toronto, Toronto, Canada.
Department of Pediatrics, University of Toronto, Toronto, Canada.

Glenda Courtney-Martin (G)

Research Institute, The Hospital for Sick Children, Toronto, Canada.
Department of Nutritional Sciences, University of Toronto, Toronto, Canada.

Rajavel Elango (R)

British Columbia Children's Hospital Research Institute, British Columbia Children's Hospital, Vancouver, Canada.
Department of Pediatrics, University of British Columbia, Vancouver, Canada.
School of Population and Public Health, University of British Columbia, Vancouver, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH